Kura Oncology, Inc.

US$7.27As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KURAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 6.01%
Div yield —
ROE (167.71%)
Biotechnology
Beta (5Y) 0.53
PE TTM —
TSR TTM (29.21%)
Mkt cap US$646.7M
ROIC (99.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.19
12.66%
(73.23%)
Buy 12|10|3|3|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.08
0.09
0.09
7.33%
20.53%
31.60%
19.00%
Revenue$M
58.19
61.02
59.61
62.93
12.06%
12.27%
10.05%
11.58%
Peers (US$646.7M)
Cap (US$)
PE
637.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.419
—
—
EBIT/Intx
0.246
1.194
0.920
Own earn%
(21.45)
(28.10)
(28.75)
Sh yield%
41.44
12.23
14.41
Owners
Insiders/Inst%
2.73
57.13
Short interest%
5.73
SBC / revenue%
5.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
8–15
$1 testx
—
Incr. ROIC%
35